Vetoquinol
Research Vetoquinol (VETO) on Bullrun: market cap EUR 837.95M, P/E 14.6, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVETO
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 837.95M
- P/E14.6
- Dividend yield1.3%
- Financial periodFY2024
- RevenueEUR 539.20M
- Revenue growth1.9%
- Net incomeEUR 58.69M
- Free cash flowEUR 68.15M
- Gross margin71.9%
Valuation Snapshot
latest market cap is EUR 837.95M; P/E is 14.6; dividend yield is 1.3%.
About Vetoquinol
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France.
Frequently asked questions
What is Vetoquinol's market cap?
Vetoquinol's market capitalization is EUR 837.95M.
What is Vetoquinol's P/E ratio?
Vetoquinol's price-to-earnings (P/E) ratio is 14.6.
Does Vetoquinol pay a dividend?
Vetoquinol has a dividend yield of 1.3%.
What does Vetoquinol do?
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation;